(Q42984509)

12 November 2017

Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection (English)

1 reference

12 November 2017

1 reference

1 reference

Kazuhiko Koike

1

1 reference

12 November 2017

16 January 2009

1 reference

Journal of Gastroenterology

12 November 2017

1 reference

12 November 2017

44 Suppl 19

1 reference

12 November 2017

82-88

1 reference

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

12 November 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-008-2276-4

Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-008-2276-4

Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein

21 January 2018

1 reference

12 December 2020

Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity

1 reference

12 December 2020

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

1 reference

12 December 2020

Does oxidative stress participate in the development of hepatocellular carcinoma?

1 reference

12 December 2020

Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humans

1 reference

12 December 2020

Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies

1 reference

12 December 2020

Hepatitis C Virus Triggers Mitochondrial Permeability Transition with Production of Reactive Oxygen Species, Leading to DNA Damage and STAT3 Activation

1 reference

12 December 2020

Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes

1 reference

12 December 2020

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

12 December 2020

Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2.

1 reference

12 December 2020

Insulin resistance and HCV: will new knowledge modify clinical management?

1 reference

12 December 2020

Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

1 reference

12 December 2020

Involvement of the PA28 -Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein

1 reference

12 December 2020

Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis

1 reference

12 December 2020

Expression of hepatitis C virus envelope proteins in transgenic mice

1 reference

12 December 2020

Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

1 reference

12 December 2020

Lessons from hereditary colorectal cancer

1 reference

12 December 2020

Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.

1 reference

12 December 2020

Steatosis: co-factor in other liver diseases.

1 reference

12 December 2020

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

1 reference

12 December 2020

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

12 December 2020

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

12 December 2020

PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice

1 reference

12 December 2020

Subcellular localization of hepatitis C virus structural proteins in the liver of transgenic mice

1 reference

12 December 2020

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

12 December 2020

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

1 reference

12 December 2020

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

12 December 2020

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

1 reference

12 December 2020

Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus

1 reference

12 December 2020

Critical role of PA28 in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis

1 reference

12 December 2020

Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations

1 reference

12 December 2020

10.1007/S00535-008-2276-4

Identifiers

DOI

1 reference

12 November 2017

1 reference

PubMed ID

19148799